Contact: Kerri Kelley; Last date for abstract submission: Not available; New research on the biologics for CNS targets and biomarkers, brain cancer, neurodegeneration, neuroinflamation, neuroimmunology, alteration of CNS/BBB barriers due to injury or disease, preclinical models, neuroimaging, and more.